Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

D Faulds, KL Goa, P Benfield - Drugs, 1993 - Springer
Cyclosporin is a lipophilic cyclic polypeptide which produces calcium-dependent, specific,
reversible inhibition of transcription of interleukin-2 and several other cytokines, most …

Cyclosporin clinical pharmacokinetics

A Fahr - Clinical pharmacokinetics, 1993 - Springer
Cyclosporin is a powerful immunosuppressive drug used in transplantation medicine and to
treat autoimmune diseases. It is a lipophilic molecule, with its bioavailability dependent on …

Therapeutic drug monitoring of immunosuppressant drugs in clinical practice

BD Kahan, P Keown, GA Levy, A Johnston - Clinical therapeutics, 2002 - Elsevier
Background: Therapeutic drug monitoring (TDM) is essential to maintain the efficacy of many
immunosuppressant drugs while minimizing their toxicity. TDM has become more refined …

Pharmacokinetics of tacrolimus in liver transplant patients

WJ Jusko, W Piekoszewski… - Clinical …, 1995 - Wiley Online Library
Objective To characterize the pharmacokinetics of the immunosuppressive agent tacrolimus
(FK 506) in liver transplant patients. Methods Patients (n= 16) were assessed during and …

Cyclosporin: a review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral®)

S Noble, A Markham - Drugs, 1995 - Springer
Synopsis The microemulsion-basedformulation of cyclosporin (Neoral®; referred to as the
microemulsion formulation in this review) is a microemulsion preconcentrate which has …

Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction …

M Gertz, CM Cartwright, MJ Hobbs… - Pharmaceutical …, 2013 - Springer
Purpose To apply physiologically-based pharmacokinetic (PBPK) modeling to investigate
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …

REDUCED INTER-AND INTRASUBJECT VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH A …

BD Kahan, J Dunn, C Fitts, D van Buren… - …, 1995 - journals.lww.com
This cross-over study compared the pharmacokinetic parameters obtained from
cyclosporine (CsA) concentration-time profiles after administration of the corn oil-based soft …

New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine

VW Armstrong, M Oellerich - Clinical biochemistry, 2001 - Elsevier
The calcineurin inhibitors cyclosporine and tacrolimus form the cornerstones of most
immunosuppression protocols. Because of their variable pharmacokinetics, and their narrow …

Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific?

W Steimer - Clinical chemistry, 1999 - academic.oup.com
Background: Immunoassays designed for the selective measurement of cyclosporin A (CsA)
inadvertently show cross-reactivity for CsA metabolites. The extent and clinical significance …

In vivo pharmacological effects of ciclosporin and some analogues

JF Borel, G Baumann, I Chapman, P Donatsch… - Advances in …, 1996 - Elsevier
Publisher Summary The powerful immunosuppressive activity of ciclosporin (CS), which is
apparently restricted at the cellular level of certain T lymphocytes, is recognized as a …